Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17367310 | 0.83 | SHMT1 (0.33) | — | |
| SCHEMBL15963400 | 0.80 | — | — | |
| SCHEMBL2160545 | 0.73 | — | — | |
| SCHEMBL16808235 | 0.71 | DUT (0.37) | DUT | |
| SCHEMBL2160386 | 0.69 | ALK (0.30) | — | |
| SCHEMBL17364121 | 0.68 | — | — | |
| SCHEMBL20496654 | 0.68 | DUT (0.39) | DUT | |
| SCHEMBL19540766 | 0.68 | — | — | |
| SCHEMBL16013569 | 0.67 | DUT (0.38) | DUT | |
| SCHEMBL12944865 | 0.66 | KDM4E (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170313652-A1 | Poly-Cyanostilbene Macrocycles | NATIONAL SCIENCE FOUNDATION | 2017-11-02 | — | — | US | disclosed |
| US-20170313652-A1 | Poly-Cyanostilbene Macrocycles | NATIONAL SCIENCE FOUNDATION | 2017-11-02 | — | — | US | disclosed |
| US-9701621-B2 | Poly-cyanostilbene macrocycles | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) | 2017-07-11 | — | — | US | disclosed |
| US-20150376122-A1 | Poly-Cyanostilbene Macrocycles | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION | 2015-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150376122-A1 | Poly-Cyanostilbene Macrocycles | PCBP1, HCCS, ACVR2B | DUT 3819/4885 |
| US-20170313652-A1 | Poly-Cyanostilbene Macrocycles | PCBP1, HCCS, ACVR2B | DUT 3819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.